Home
CME Articles
Current Issue
Back Issues
About the Journal
Contact Us

Ledford, Little Eye Book, Second Edition

  This continuing medical education activity is sponsored by Vindico Medical Education.


Review Article
Organoid Nevus Syndrome: Manifestations and Management
Journal of Pediatric Ophthalmology and Strabismus   Vol. 40   No. 3   May/June 2003
Rudolph S. Wagner, MD and John M. Facciani, MD
Privacy System Contact us

Share/Save/Bookmark


EXCERPT

The organoid nevus syndrome is an oculoneurocutaneous disorder that usually presents at birth with unilateral or bilateral epibulbar choristomas and organoid nevus of the face or scalp and within the first decade of life with neurologic abnormalities. 1 There is no consistent familial pattern of inheritance, or sexual or racial predilection. The syndrome may present with some or all of the features described in this article. The most common findings are cutaneous, neurologic, and ophthalmologic. As with other phakomatoses, other organs may be involved. We report a case of organoid nevus syndrome that demonstrates the ability to diagnose this condition on clinical grounds and initiate an appropriate systemic workup; treatment considerations for patients with this syndrome; and a previously unreported feature of the syndrome.

AUTHORS

Dr. Wagner is from the Institute of Ophthalmology and Visual Science, New Jersey Medical School; and Dr. Facciani is from the Institute of Ophthalmology and Visual Science, New Jersey Medical School, Newark, NJ.

Originally submitted October 31, 2002.

Accepted for publication December 13, 2002.

Address reprint requests to Rudolph S. Wagner, MD, Institute of Ophthalmology and Visual Science, New Jersey Medical School, 90 Bergen Street, Doctors Office Center 6th Floor, Newark, NJ 07107.

Supported by an unrestricted grant from Research to Prevent Blindness, Inc., and the Lion’s Eye Research Foundation of New Jersey.

The authors have no industry relationships to disclose.

In accordance with ACCME policies, the audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage.

The material presented at or in any SLACK Incorporated continuing medical education activities does not necessarily reflect the views and opinions of SLACK Incorporated. Neither SLACK Incorporated nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the U.S. Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.